| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.095 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |